Trim 30-40% ORCL exposure at $142-145; maintain residual 1.5-2% with $128 hard stop and $130/$110 put spreads
The Underweight rating reflects intact structural floor (rules out Sell) combined with broken technicals and new negative catalysts including Wisconsin timeline slippage, Morgan Stanley withholding Buy despite 50% upside, contaminated OCF surge, falling 200-SMA, fresh MACD bearish cross, and weak RSI. The 30-40% trim magnitude is calibrated between the 9/24 downtrim imperative and the 9/28 floor lesson—honoring structural floor support while executing position reduction. Reject the trader's $148/$152 tactical short as the 0.57x ATR stop is insufficient for a beta-1.73 name with $7.03 ATR; instead, use defined-risk put spreads to express bearish view with bounded downside. Upgrade to Hold on confirmed close >$155 with >20M volume and positive MACD histogram turn, or clean Q2 FY26 earnings with moderating capex and >$50B sequential RPO growth, or AI credit spreads tightening below 250bps.
| Position | Action |
|---|---|
| Structural floor intact + new negative catalysts + confirmed downtrend | Trim 30-40% of ORCL exposure via limit orders at $142-145 with 5-day time stop; fall back to market trim if no relief bounce materializes |
| After trim execution | Maintain residual position at ~1.5-2% of book |
| Residual position size exceeds 2% AND structural thesis fails ($114.50 stop triggered) | Full exit of position warranted |
| Expressing bearish tactical view | December $130/$110 put spreads at 2-3% of residual position notional (defined-risk, not stock short) |
| Scale-in on failed retests | Scale-in shorts on confirmed failed retests of $142-147 resistance zone with 1.0 ATR stops (~$135) |
Oracle is a structurally healthy, high-growth enterprise software leader undergoing necessary AI infrastructure transformation, mispriced by a market conflating investment-phase negative FCF with a broken business model.
| Indicator | Value | Signal |
|---|---|---|
| 50 SMA | 142.90 | bearish |
| 200 SMA | 162.66 | bearish |
| 10 EMA | 140.86 | bearish |
| RSI(14) | 42.68 | bearish |
| RSI Peak | 63.43 (2026-09-08) | bearish |
| MACD Line | -2.66 | bearish |
| MACD Signal | -1.02 | bearish |
| MACD Histogram | -1.64 | bearish |
| Bollinger Middle Band | 146.95 | bearish |
| Bollinger Upper Band | 163.63 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed failed retest of $142-147 resistance zone
Then: Scale-in stock shorts with 1.0 ATR stops (~$135)
Negative FCF is investment-phase cash deployment, not a broken business model — operating cash flow is inflecting sharply
EV: +45%+ (Target 3: $180+ on FCF inflection) · concedes: Wisconsin delay is real and will push timeline back; capex normalization expected 2027-2028 before FCF inflects sharply positive; bond spreads could widen further near-term; Q2 earnings must show operating leverage holding
Oracle requires five independent miracles (timely Wisconsin completion, capex normalization, AI demand materialization, bond spread compression, and $11 EPS achievement) while the bear case needs only continued execution slippage — and all early indicators show slippage is already occurring.
EV: Target 1: $121 (July swing low); Target 2: $115 (52-week low break); Target 3: $100-105 (capitulation target with re-test of 2025 support zone) · concedes: Forward P/E of 12.49x with PEG of 0.77 is an attractive metric IF execution occurs; Technical levels at $137 provide historical support; There is theoretical upside case of $162 base / $180+ expansion (18-45%+ upside) if all bull catalysts materialize
→ vs conservative: Wait-and-see approach turns clean short into painful squeeze; confirmation is already present in RSI 42.68, bearish MACD cross, and volume spikes of 80.4 million shares on down days
→ vs conservative: Morgan Stanley sees 50% upside yet refuses to issue Buy — 'most aggressive bull' won't underwrite the trade, signaling stress test ORCL cannot pass
→ vs conservative: Bond market pricing 8% on supposedly investment-grade tech debt is the market doing its job; fighting bond market is losing trade
→ vs conservative: Amazon's worst FCF year during entire AWS buildout was negative 2.7 billion; Oracle running negative 45.85 billion TTM is structurally disconnected from cash generation
→ vs conservative: Waiting for stabilization means paying 20-point premium (110 vs 148 entry) for privilege of being right later
→ vs conservative: High beta of 1.73 does not preclude short; position size accordingly at 1-2% portfolio risk maximum
→ vs neutral: Forward P/E 12.49 and PEG 0.77 is the bear thesis in disguise — requires 72% EPS growth from 6.38 to 11.00 with near-perfect execution in deteriorating environment
→ vs neutral: OCF inflection from 2.1 billion to 23.1 billion is 'mirage' — 1,018% surge driven by 13.9 billion deferred revenue pull-forward masking 45.85 billion FCF burn
→ vs neutral: Revenue growing 29.6% YoY and operating margin at 35.6% are already priced in at 12.5x forward multiple with 0.77 PEG — does not compensate for refinancing, execution, regulatory, or macro risks
→ vs neutral: Split-the-difference 'hold' thesis ignores bond market screaming 8% yields on IG tech debt, 350 bps wider than comp set
→ vs neutral: Quality of earnings matters more than quantity; 204% PPE increase and 251.7% debt-to-equity signal structural capital intensity problem
| Bollinger Lower Band |
| 130.28 |
| bearish |
| ATR(14) | 7.03 | bearish |
| ATR as % of Price | 5.1% | bearish |
| VWMA(20) | 144.24 | bearish |
| YTD High | 249.38 (2026-06-01) | bearish |
| Price | 137.30 | bearish |
Support: 130.28 · 130.27 · 121.38 · 114.99 | Resistance: 140.86 · 142.9 · 144.24 · 146.95 · 162.66 · 163.63
ORCL is in active distribution with all three MAs above price and MACD in a fresh bearish crossover. The 200 SMA (162.66) remains a falling "ceiling" with price nearly 16% below it. ATR at 7.03 (5.1% of price) signals elevated volatility requiring wider stops and smaller position sizing. RSI at 42.68 has not reached oversold territory (<30), meaning downside momentum is not yet exhausted. VWMA at 144.24 shows sellers in control but decelerating. Key immediate resistance sits at 140.86–142.90; a close above 142.90 would be the first tactical bullish trigger. Support clusters at 130.28 (Bollinger lower/ATR-1× confluence); a break below opens measured move to July swing lows at 121.38 and 114.99. The report recommends HOLD for existing longs with defensive positioning and advises new entries to await either RSI <30 with bullish MACD divergence or a weekly close above 162.66.
Market Capitalization
$416.2 Billion
Beta
1.732
P/E Ratio (TTM)
21.52
Forward P/E
12.49
PEG Ratio
0.77
Price/Book
6.72
EPS (TTM)
$6.38
Forward EPS
$11.00
Dividend Yield
1.45%
52-Week Range
$114.50 – $322.54
Implied Current Price
~$137.60
Revenue Growth (YoY)
+29.6%
EBITDA Growth (YoY)
+69.8%
Net Income Growth (YoY)
+62.6%
Diluted EPS Growth (YoY)
+54.5%
Gross Margin (TTM)
63.95%
Operating Margin (TTM)
35.63%
Net Margin (TTM)
26.36%
ROE
41.19%
ROA
6.36%
TTM Revenue
$71.78B
TTM Gross Profit
$45.91B
TTM EBITDA
$34.43B
TTM Net Income
$18.74B
Total Assets
$303.3B
Total Liabilities
$236.1B
Stockholders Equity
$66.8B
Total Debt
$155.9B
Cash & Equivalents
$36.4B
Net Debt
$89.0B
Net PPE
$161.8B
Goodwill
$62.3B
Current Ratio
1.17
Debt/Equity
251.7%
Capital Lease Obligations
$30.6B
Operating Cash Flow (TTM)
~$52.0B
Free Cash Flow (TTM)
-$45.85B
Capex (Quarterly)
$28.5B
Q Aug 2026 Operating CF
$23,103M
Q Aug 2026 Capex
$28,499M
Q Aug 2026 Free Cash Flow
-$5,396M
Recent Equity Issuance
$19.9B
Recent Preferred Stock
$4.95B
Strengths
Concerns
Oracle is undergoing a transformative heavy investment phase, having more than tripled its net property, plant and equipment to $161.8B (+204% YoY) to fund an aggressive AI/cloud infrastructure buildout. The company is generating strong fundamental momentum with 29.6% YoY revenue growth, 35.63% operating margins, and 41.19% ROE, while operating cash flow has surged from $2.1B to $23.1B in just three quarters. Despite these strengths, the stock has pulled back ~57% from its 52-week high of $322.54 to ~$137.60, trading at a discounted forward P/E of 12.49x and PEG of 0.77 that suggests potential undervaluation if Oracle executes on its infrastructure investments.